Skip to main content
. 2018 Dec 26;155(3):519–527. doi: 10.1016/j.chest.2018.11.028

Figure 3.

Figure 3

Association of aspirin use with incidence of COPD exacerbations, based on presence of chronic bronchitis at baseline, COPD severity, presence of emphysema (≥ 5%), and presence of cardiometabolic phenotype at baseline. GOLD = Global Initiative for Chronic Obstructive Lung Disease; MDCT = multidetector row CT; P-int = P value for interaction with aspirin use.